Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis, study finds
Links shared publicly online about this topic.
- 454total visits
Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis, study finds
View full resource at sciencedaily.com
Tags: Skin, Erectile Dysfunction Medication, Neurovascular Disorder, Raynaud Disease, Scleroderma, Viagra
Most Recently Shared on March 8, 2011 at 2:51 pm By:
Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis, study finds http://bit.ly/fgtz5G
Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis, study finds
sciencedaily.com — “Researchers in Europe report that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud’s phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The double-blind, placebo-controlled trial found that sildenafil was well tolerated with only some subjects experiencing minor or moderate side effects.” View full resource at sciencedaily.com
Most Recently Shared on March 8, 2011 at 2:20 pm By:
Sildenafil reduces Raynaud's frequency in patients with systemic sclerosis, study finds: Researchers in Europe r... http://bit.ly/eMhWKt
Advertisement
